Titre : Protéines d'activation de la GTPase

Protéines d'activation de la GTPase : Questions médicales fréquentes

Termes MeSH sélectionnés :

Visual Fields

Questions fréquentes et termes MeSH associés

Général 1

#1

Erreur lors de la génération.

Veuillez réessayer ultérieurement.
GTPase-Activating Proteins
{ "@context": "https://schema.org", "@graph": [ { "@type": "MedicalWebPage", "name": "Protéines d'activation de la GTPase : Questions médicales les plus fréquentes", "headline": "Protéines d'activation de la GTPase : Comprendre les symptômes, diagnostics et traitements", "description": "Guide complet et accessible sur les Protéines d'activation de la GTPase : explications, diagnostics, traitements et prévention. Information médicale validée destinée aux patients.", "datePublished": "2024-07-25", "dateModified": "2025-04-21", "inLanguage": "fr", "medicalAudience": [ { "@type": "MedicalAudience", "name": "Grand public", "audienceType": "Patient", "healthCondition": { "@type": "MedicalCondition", "name": "Protéines d'activation de la GTPase" }, "suggestedMinAge": 18, "suggestedGender": "unisex" }, { "@type": "MedicalAudience", "name": "Médecins", "audienceType": "Physician", "geographicArea": { "@type": "AdministrativeArea", "name": "France" } }, { "@type": "MedicalAudience", "name": "Chercheurs", "audienceType": "Researcher", "geographicArea": { "@type": "AdministrativeArea", "name": "International" } } ], "reviewedBy": { "@type": "Person", "name": "Dr Olivier Menir", "jobTitle": "Expert en Médecine", "description": "Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale", "url": "/static/pages/docteur-olivier-menir.html", "alumniOf": { "@type": "EducationalOrganization", "name": "Université Paris Descartes" } }, "isPartOf": { "@type": "MedicalWebPage", "name": "Régulateurs des protéines G", "url": "https://questionsmedicales.fr/mesh/D020555", "about": { "@type": "MedicalCondition", "name": "Régulateurs des protéines G", "code": { "@type": "MedicalCode", "code": "D020555", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D12.776.476.325" } } }, "hasPart": [ { "@type": "MedicalWebPage", "name": "Protéines d'activation de la ras GTPase", "alternateName": "ras GTPase-Activating Proteins", "url": "https://questionsmedicales.fr/mesh/D020703", "about": { "@type": "MedicalCondition", "name": "Protéines d'activation de la ras GTPase", "code": { "@type": "MedicalCode", "code": "D020703", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D12.776.476.325.150.500" } }, "hasPart": [ { "@type": "MedicalWebPage", "name": "Protéine p120 d'activation de la ras GTPase", "alternateName": "p120 GTPase Activating Protein", "url": "https://questionsmedicales.fr/mesh/D020729", "about": { "@type": "MedicalCondition", "name": "Protéine p120 d'activation de la ras GTPase", "code": { "@type": "MedicalCode", "code": "D020729", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D12.776.476.325.150.500.500" } } } ] }, { "@type": "MedicalWebPage", "name": "Protéines RGS", "alternateName": "RGS Proteins", "url": "https://questionsmedicales.fr/mesh/D020710", "about": { "@type": "MedicalCondition", "name": "Protéines RGS", "code": { "@type": "MedicalCode", "code": "D020710", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D12.776.476.325.150.750" } } } ], "about": { "@type": "MedicalCondition", "name": "Protéines d'activation de la GTPase", "alternateName": "GTPase-Activating Proteins", "code": { "@type": "MedicalCode", "code": "D020690", "codingSystem": "MeSH" } }, "author": [ { "@type": "Person", "name": "René Rasche", "url": "https://questionsmedicales.fr/author/Ren%C3%A9%20Rasche", "affiliation": { "@type": "Organization", "name": "Institute of Biochemistry, University Münster, Germany." } }, { "@type": "Person", "name": "Daniel Kümmel", "url": "https://questionsmedicales.fr/author/Daniel%20K%C3%BCmmel", "affiliation": { "@type": "Organization", "name": "Institute of Biochemistry, University Münster, Germany." } }, { "@type": "Person", "name": "Manil Kanade", "url": "https://questionsmedicales.fr/author/Manil%20Kanade", "affiliation": { "@type": "Organization", "name": "Indian Institute of Science Education and Research, Pune, India." } }, { "@type": "Person", "name": "Pananghat Gayathri", "url": "https://questionsmedicales.fr/author/Pananghat%20Gayathri", "affiliation": { "@type": "Organization", "name": "Indian Institute of Science Education and Research, Pune, India." } }, { "@type": "Person", "name": "Qingqing Dai", "url": "https://questionsmedicales.fr/author/Qingqing%20Dai", "affiliation": { "@type": "Organization", "name": "Department of Internal Medicine IV (Gastroenterology, Hepatology, and Infectious Diseases), Jena University Hospital, Jena, Germany." } } ], "citation": [ { "@type": "ScholarlyArticle", "name": "Visual Field Coordinate Systems in Visual Neurophysiology.", "datePublished": "2023-05-08", "url": "https://questionsmedicales.fr/article/37162088", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1590/0001-3765202320220381" } }, { "@type": "ScholarlyArticle", "name": "Visual Fields in Epidemic Retinitis.", "datePublished": "2022-06-16", "url": "https://questionsmedicales.fr/article/35708453", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1080/09273948.2022.2084422" } }, { "@type": "ScholarlyArticle", "name": "Visual field asymmetries in numerosity processing.", "datePublished": "2022-10-18", "url": "https://questionsmedicales.fr/article/36258143", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.3758/s13414-022-02585-1" } }, { "@type": "ScholarlyArticle", "name": "Assessment of visual field progression in glaucoma.", "datePublished": "2022-11-15", "url": "https://questionsmedicales.fr/article/36378107", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1097/ICU.0000000000000932" } }, { "@type": "ScholarlyArticle", "name": "Performance of VisuALL virtual reality visual field testing in healthy children.", "datePublished": "2024-01-14", "url": "https://questionsmedicales.fr/article/38219921", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1016/j.jaapos.2023.10.004" } } ], "breadcrumb": { "@type": "BreadcrumbList", "itemListElement": [ { "@type": "ListItem", "position": 1, "name": "questionsmedicales.fr", "item": "https://questionsmedicales.fr" }, { "@type": "ListItem", "position": 2, "name": "Acides aminés, peptides et protéines", "item": "https://questionsmedicales.fr/mesh/D000602" }, { "@type": "ListItem", "position": 3, "name": "Protéines", "item": "https://questionsmedicales.fr/mesh/D011506" }, { "@type": "ListItem", "position": 4, "name": "Protéines et peptides de signalisation intracellulaire", "item": "https://questionsmedicales.fr/mesh/D047908" }, { "@type": "ListItem", "position": 5, "name": "Régulateurs des protéines G", "item": "https://questionsmedicales.fr/mesh/D020555" }, { "@type": "ListItem", "position": 6, "name": "Protéines d'activation de la GTPase", "item": "https://questionsmedicales.fr/mesh/D020690" } ] } }, { "@type": "MedicalWebPage", "name": "Article complet : Protéines d'activation de la GTPase - Questions et réponses", "headline": "Questions et réponses médicales fréquentes sur Protéines d'activation de la GTPase", "description": "Une compilation de questions et réponses structurées, validées par des experts médicaux.", "datePublished": "2025-05-14", "inLanguage": "fr", "hasPart": [ { "@type": "MedicalWebPage", "name": "Général", "headline": "Général sur Protéines d'activation de la GTPase", "description": "Erreur lors de la génération.", "url": "https://questionsmedicales.fr/mesh/D020690?mesh_terms=Visual+Fields#section-général" } ] }, { "@type": "FAQPage", "mainEntity": [ { "@type": "Question", "name": "Erreur lors de la génération.", "position": 1, "acceptedAnswer": { "@type": "Answer", "text": "Veuillez réessayer ultérieurement." } } ] } ] }
Dr Olivier Menir

Contenu validé par Dr Olivier Menir

Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale


Validation scientifique effectuée le 21/04/2025

Contenu vérifié selon les dernières recommandations médicales

Auteurs principaux

René Rasche

2 publications dans cette catégorie

Affiliations :
  • Institute of Biochemistry, University Münster, Germany.

Daniel Kümmel

2 publications dans cette catégorie

Affiliations :
  • Institute of Biochemistry, University Münster, Germany.

Manil Kanade

2 publications dans cette catégorie

Affiliations :
  • Indian Institute of Science Education and Research, Pune, India.

Pananghat Gayathri

2 publications dans cette catégorie

Affiliations :
  • Indian Institute of Science Education and Research, Pune, India.

Qingqing Dai

2 publications dans cette catégorie

Affiliations :
  • Department of Internal Medicine IV (Gastroenterology, Hepatology, and Infectious Diseases), Jena University Hospital, Jena, Germany.
  • Else Kröner Graduate School for Medical Students "Jena School for Ageing Medicine (JSAM)", Jena University Hospital, Jena, Germany.

Fei Song

2 publications dans cette catégorie

Affiliations :
  • Department of Urology, Jena University Hospital, Jena, Germany.

Jun Matsuda

2 publications dans cette catégorie

Affiliations :
  • Division of Nephrology, McGill University Health Centre, Montreal, Quebec, Canada; Research Institute, McGill University Health Centre, Montreal, Quebec, Canada.
Publications dans "Protéines d'activation de la GTPase" :

Tomoko Takano

2 publications dans cette catégorie

Affiliations :
  • Division of Nephrology, McGill University Health Centre, Montreal, Quebec, Canada; Research Institute, McGill University Health Centre, Montreal, Quebec, Canada. Electronic address: tomoko.takano@mcgill.ca.
Publications dans "Protéines d'activation de la GTPase" :

Qiaojia Zheng

2 publications dans cette catégorie

Affiliations :
  • Marine and Agricultural Biotechnology Laboratory, Institute of Oceanography, Minjiang University, Fuzhou, China.

Zhi Yu

2 publications dans cette catégorie

Affiliations :
  • Marine and Agricultural Biotechnology Laboratory, Institute of Oceanography, Minjiang University, Fuzhou, China.
  • College of Life Sciences, Fujian Agriculture and Forestry University, Fuzhou, China.

Yanping Yuan

2 publications dans cette catégorie

Affiliations :
  • College of Life Sciences, Fujian Agriculture and Forestry University, Fuzhou, China.

Danli Sun

2 publications dans cette catégorie

Affiliations :
  • Marine and Agricultural Biotechnology Laboratory, Institute of Oceanography, Minjiang University, Fuzhou, China.

Yakubu Saddeeq Abubakar

2 publications dans cette catégorie

Affiliations :
  • Department of Biochemistry, Faculty of Life Sciences, Ahmadu Bello University, Zaria, Nigeria.

Jie Zhou

2 publications dans cette catégorie

Affiliations :
  • College of Life Sciences, Fujian Agriculture and Forestry University, Fuzhou, China.

Zonghua Wang

2 publications dans cette catégorie

Affiliations :
  • Marine and Agricultural Biotechnology Laboratory, Institute of Oceanography, Minjiang University, Fuzhou, China.
  • College of Life Sciences, Fujian Agriculture and Forestry University, Fuzhou, China.

Huawei Zheng

2 publications dans cette catégorie

Affiliations :
  • Marine and Agricultural Biotechnology Laboratory, Institute of Oceanography, Minjiang University, Fuzhou, China.

Lorna O'Donoghue

1 publication dans cette catégorie

Affiliations :
  • UCD School of Medicine, University College Dublin, UCD Conway Institute, Belfield, Dublin 4, Ireland.
  • Irish Centre for Vascular Biology, Royal College of Surgeons in Ireland, 123 St. Stephen's Green 123, Dublin 2, Ireland.
Publications dans "Protéines d'activation de la GTPase" :

Albert Smolenski

1 publication dans cette catégorie

Affiliations :
  • UCD School of Medicine, University College Dublin, UCD Conway Institute, Belfield, Dublin 4, Ireland.
  • Irish Centre for Vascular Biology, Royal College of Surgeons in Ireland, 123 St. Stephen's Green 123, Dublin 2, Ireland.
Publications dans "Protéines d'activation de la GTPase" :

Yu Huang

1 publication dans cette catégorie

Affiliations :
  • Institute of Modern Biopharmaceuticals, State Key Laboratory Breeding Base of Eco-Environment and Bio-Resource of the Three Gorges Area, Key Laboratory of Eco-Environments in Three Gorges Reservoir Region, Ministry of Education, School of Life Sciences, Southwest University, Chongqing, China.

Shuangquan Yan

1 publication dans cette catégorie

Affiliations :
  • Institute of Modern Biopharmaceuticals, State Key Laboratory Breeding Base of Eco-Environment and Bio-Resource of the Three Gorges Area, Key Laboratory of Eco-Environments in Three Gorges Reservoir Region, Ministry of Education, School of Life Sciences, Southwest University, Chongqing, China.

Sources (10000 au total)

Visual Fields in Epidemic Retinitis.

The aim of the study is to analyze visual fields defects (VFDs) in epidemic retinitis (ER).... Patients with ER and Humphrey's visual field (HFA) 30-2 performed after resolution were studied. VFD severity grading was performed. Patients treated with oral doxycycline (Group-A) versus doxycycline... Thirty-five eyes of 25 patients were studied. Nasal, inferior, temporal and central VFD were seen in 19 (54.2%), 13 (37.1%), 7 (20%) and 6 (17.1%) eyes, respectively. Grade 0, 1, 2 and 3 VFDs were see... ER can cause VFD persisting long after resolution. Treatment with oral doxycycline without steroids was non-inferior to combined treatment with respect to VFD....

Assessment of visual field progression in glaucoma.

Perimetry plays an important role in the diagnosis and management of glaucoma. This article discusses the assessment of visual field progression in patients with glaucoma.... Selecting the best visual field test strategy and establishing a baseline of visual fields will assist clinicians in the detection of glaucomatous progression. Repeat testing serves to confirm or refu... Many treated patients with glaucoma will experience visual field progression. Optimal utilization of visual field testing strategy and analytical software can help clinicians identify patients with gl...

Performance of VisuALL virtual reality visual field testing in healthy children.

Virtual reality field testing may provide an alternative to standard automated perimetry. This study evaluates a virtual reality game-based automated perimetry in a healthy pediatric population.... A prospective series of pediatric patients at one institution who performed VisuALL perimetry (Olleyes Inc, Summit, NJ) using a game-based algorithm. Participants were examined by an experienced pedia... A total of 191 eyes of 97 patients (54% female) were included, with a mean age of 11.9 ± 3.1 years. The average MD was -1.82 ± 3.5 dB, with a mean foveal sensitivity of 32.0 ± 4.7 dB. Fifty-nine eyes ... VisuALL virtual reality field testing was well tolerated in this pediatric study cohort. Older age and shorter test duration were associated with better performance on field testing....

Visual Field Defect Patterns Associated With Lesions of the Retrochiasmal Visual Pathway.

Perimetry is widely used in the localization of retrochiasmal visual pathway lesions. Although macular sparing, homonymous paracentral scotomas, and quadrantanopias are regarded as features of posteri... Retrospective record review conducted in a single, academic, medical center using an electronic search engine with the terms ""homonymous hemianopia," "optic tract," "temporal lobectomy," "visual fiel... From an original cohort of 256 cases, only 83 had MRI-defined lesions that were limited to particular retrochiasmal segments and had visual field defect patterns that allegedly permitted localization ... In correlating discrete MRI-defined retrochiasmal lesions with visual field defect patterns identified on static perimetry, this study showed that macular sparing, homonymous paracentral scotomas, and...

Comparison of the visual field test of Glaufield Lite with Humphrey Field Analyser.

To compare visual field test results of Glaufield Lite AP901 CTS 133 (Appasamy Associates, Mannadipet Commune, Thirubhuvanai, Puducherry, India, hereafter Glaufield Lite) with Humphrey Field Analyser ... A pilot study at a tertiary eye centre involving 23 normal and 24 glaucoma patients who underwent two consecutive visual field tests on (i) HFA 24-2 SITA Fast and (ii) Glaufield Lite Quick Central pro... The mean testing time on HFA was significantly shorter than Glaufield Lite (normals: HFA: 2.75 ± 0.49 min, Glaufield Lite: 6.85 ± 0.86 min, p < 0.001; glaucoma patients: HFA: 3.45 ± 1.08 min, Glaufiel... Both perimetric techniques showed reliable test results though test duration was longer with Glaufield Lite perimetry. The MD showed poor agreement, likely due to different scales and principles used ...